BIOMAT Database Logo BIOMAT Database Logo

Symposium. The introduction of biologics in orthopaedics: issues of cost, commercialism, and ethics. 2007

William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Vanderbilt Orthopedic Trauma, Medical Center East-South Tower, Suite 4200, Nashville, TN 37232-8774, USA. william.obremskey@vanderbilt.edu

UI MeSH Term Description Entries
D009985 Orthopedics A specialty which utilizes medical, surgical, and physical methods to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.
D010983 Plateletpheresis The preparation of platelet concentrates with the return of red cells and platelet-poor plasma to the donor. Blood Plateletpheresis,Thrombocytapheresis,Thrombocytopheresis,Blood Plateletphereses,Plateletphereses,Plateletphereses, Blood,Plateletpheresis, Blood,Thrombocytaphereses,Thrombocytophereses
D003132 Commerce The interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade (the buying, selling, or exchanging of commodities, whether wholesale or retail) and business (the purchase and sale of goods to make a profit). (From Random House Unabridged Dictionary, 2d ed, p411, p2005 & p283) Business,Commercial Sector,Prices,Sales,Vendors,Businesses,Commerces,Commercial Sectors,Price,Sale,Sector, Commercial,Sectors, Commercial,Vendor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D013673 Technology Assessment, Biomedical Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. Assessment, Biomedical Technology,Assessment, Technology,Biomedical Technology Assessment,Technology Assessment,Technology Assessment, Health,Assessment, Health Technology,Assessments, Biomedical Technology,Assessments, Health Technology,Assessments, Technology,Biomedical Technology Assessments,Health Technology Assessment,Health Technology Assessments,Technology Assessments,Technology Assessments, Biomedical,Technology Assessments, Health
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D017277 Drug Approval Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug. Drug Approval Process,New Drug Approval,Food and Drug Administration Drug Approval,Food and Drug Administration Drug Approval Process,New Drug Approval Process,Approval Process, Drug,Approval Processes, Drug,Approval, Drug,Approval, New Drug,Approvals, Drug,Approvals, New Drug,Drug Approval Processes,Drug Approval, New,Drug Approvals,Drug Approvals, New,New Drug Approvals,Process, Drug Approval,Processes, Drug Approval
D053657 Platelet-Rich Plasma A preparation consisting of PLATELETS concentrated in a limited volume of PLASMA. This is used in various surgical tissue regeneration procedures where the GROWTH FACTORS in the platelets enhance wound healing and regeneration. Plasma, Platelet-Rich,Platelet Rich Plasma
D019485 Bone Morphogenetic Proteins Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins. Bone Morphogenetic Protein,Morphogenetic Protein, Bone,Morphogenetic Proteins, Bone

Related Publications

William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Editorial comment: symposium: biologics and tissue healing in orthopaedics.
May 2015, Clinical orthopaedics and related research,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Introduction to the symposium. Comparative orthopaedics.
January 1969, Clinical orthopaedics and related research,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Issues in medical ethics. Introduction.
May 1989, The Mount Sinai journal of medicine, New York,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Ethics versus commercialism in the professions.
October 2000, Annals of the Royal Australasian College of Dental Surgeons,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
[Orthopaedics issues by sport overuse in children and adolescents. Introduction].
June 2010, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Spectre of commercialism dominates transplant symposium.
August 1985, Canadian Medical Association journal,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Sociological and ethical issues in transplant commercialism.
April 2009, Current opinion in organ transplantation,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Issues in clinical ethics consultation: an introduction.
March 1992, Theoretical medicine,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
Health care issues and the uninsured: a symposium. Introduction.
January 1989, Journal of health and human resources administration,
William T Obremskey, and James S Marotta, and Michael J Yaszemski, and Larry R Churchill, and Scott D Boden, and Douglas R Dirschl
ISAKOS knee committee: biologics in orthopaedics.
April 2015, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association,
Copied contents to your clipboard!